6
Participants
Start Date
December 31, 2006
Primary Completion Date
January 31, 2010
Study Completion Date
March 31, 2010
Rituximab
1000mg (1gm) given as an IV infusion every two weeks for 2 doses (days 1 and 15). The first infusion of rituximab should be administered IV at an initial rate of 50 mg/hr. If a hypersensitivity or infusion related reaction does not occur, escalate the infusion rate by 50 mg/hr increments every 30 minutes, to a maximum of 400 mg/hr.
University of Rochester, Rochester
Swedish Rheumatology Research, Seattle
University of California, San Diego, La Jolla
Stanford University, Stanford
Collaborators (1)
Genentech, Inc.
INDUSTRY
Swedish Medical Center
OTHER